Ladda ner den kompletta programboken här! - SFAI-veckan 2013

More documents

Recommendations

Info

NEW METHODS FOR NEUROPATHIC PAIN TREATMENT SAL 2 16.00-17.30 EVIDENCE-BASED TREATMENT OF NEUROPATHIC PAIN Per Hansson, Professor/senior consultant/section head, Section of neuropathic pain, Pain center, Dept. of Anesthesiology and Intensive Care, Karolinska University Hospital, Solna, Several guidelines for pharmacological treatment of neuropathic pain have been published in recent years. The lecture will highlight the recommendations published in 2010 by the European Federation of Neurological Societies (EFNS). In addition, the EFNS guidelines on neurostimulation will be briefly reviewed. NON-INVASIVE BRAIN STIMULATION: A NEW TREATMENT OPTION FOR PAIN Didier Bouhassira, MD, PhD, INSERM U987, « Pathophysiology and Clinical Pharmacology of Pain » Ambroise Pare Hospital, 92100 Boulogne-Billancourt, France Repetitive Transcranial Magnetic Stimulation (rTMS) and transcranial Direct Current Stimulation (tDCS) are non invasive brain stimulation (NIBS) techniques which have raised an increasing interest in recent years for the treatment of various pain conditions, including not only peripheral and central neuropathic pain syndromes, but also non neuropathic pain syndromes such as fibromyalgia. A large number of randomized sham-controlled trials have confirmed that it is possible to induce analgesic effects lasting up to several days after a single session of stimulation of the primary motor cortex or dorsolateral prefrontal cortex. More recently, it has been shown that it is possible to maintain the analgesic effects of rTMS of the primary motor cortex in patients with chronic pain over more than 6 months, strengthening the idea that NIBS could represent a valid option for the treatment of chronic pain patients. Although the mechanisms of the analgesic action of NIBS are still poorly understood, recent studies have suggested that they depend on endogenous opioid system and changes in cortical excitability. CAPSAICIN FOR PERIPHERAL NEUROPATHIC PAIN Per Hansson, Professor/senior consultant/section head, Section of neuropathic pain, Pain center, Dept. of Anesthesiology and Intensive Care, Karolinska University Hospital, Solna Qutenza is a dermal patch of high-concentration capsaicin (8%) developed to rapidly deliver a therapeutic dose of capsaicin into the skin. Qutenza is indicated for the treatment of peripheral neuropathic pain in nondiabetic adults. Approval of the drug by the European Medicinal Agency was based on clinical trials conducted in adult patients with post herpetic neuralgia or HIV- associated painful polyneuropathy. The lecture will probe mechanisms of action of capsaicin, review recently published studies on Qutenza and results from a recent Swedish multicenter observational study. PROGRAM 26
TORSDAG 20/9 MARTIN H:SON HOLMDAHLS HÖGTIDSFÖRELÄSNING SAL 1 08.00-08.45 ANESTHESIA IN AN ASYMMETRICAL WORLD Angela Enright, Presi<strong>den</strong>t of World Federation of Societies of Anaesthesiologists It is only in recent years that major organizations such as the World Health Organization (WHO) have begun to pay any attention to surgery and anesthesia. Surgery was considered too expensive for low-income countries. Yet surgical problems occupy at least 11% of the bur<strong>den</strong> of disease. Many conditions can be treated easily, quickly and at low cost. In its Safe Surgery Saves Lives campaign of 2008, WHO recognized that without safe anesthesia there can be no safe surgery. The provision of safe anesthesia in all areas of the world brings many challenges. Anesthesia mortality rates in high-income countries have diminished steadily to about 1:250,000. Compare that to a mortality rate of about 1:150 in some low-income countries. There are many reasons why this is the case – lack of basic resources such a continual supply of electricity and water, lack of anesthesia resources such as drugs and functioning equipment, long distances travelled by patients who may arrive in a terminal state, but probably the major cause is a lack of trained providers of anesthesia. This does not necessarily mean only specialist physicians, who are in very short supply, but also the non-physician providers who deliver most of the anesthesia care in low- and middle-income countries (LMICs). Anesthesia is often given by people without any anesthesia training at all. The World Federation of Societies of Anaesthesiologists supports educational activities in a variety of ways. There are basic and sub-specialty programs in anesthesia in many parts of the world. These provide training in a variety of areas such as pediatric anesthesia, obstetrical anesthesia, cardiac anesthesia, pain management, intensive care and regional anesthesia. WFSA experience shows that the young physician graduates from these programs return home and share their knowledge with their colleagues. They are also able to effect changes in how anesthesia is practiced in their own departments and countries. They are encouraged to teach the non-physician providers and to develop continuing medical education programs for them. WFSA also provides educational material in the form of a journal - Update in Anaesthesia - which is available free of charge, and also Tutorial of the Week which is a peer-reviewed tutorial available on line. In addition, WFSA produces and distributes other learning materials such as a CDROMs on obstetric anesthesia and a books on pediatric and obstetric anesthesia. A major programme to improve the quality of teaching was developed in recent years. This has now been used in 22 countries in Europe and has begun in Latin America. WFSA has published Standards for the Safe Practice of Anaesthesia and works to improve patient safety in anesthesia. The Lifebox project provides suitable pulse oximeters, with the accompanying education, for anesthesia providers in LMICs. Anesthesia societies all over the world have joined with the WFSA in this effort. The improvements in anesthesia care as a result of these efforts could save millions of patients’ lives. 27 PROGRAM
Page 1 and 2: SFAI-veckan 2012 19-21 september |
Page 3 and 4: ÖVERSIKT AV PROGRAMINNEHÅLL VÄLK
Page 5 and 6: Om Borås Borås är Sveriges 13:e
Page 7 and 8: Allmän information Garderob Garder
Page 9 and 10: Kurser och möten SFAI:s styrelsem
Page 11 and 12: GE Healthcare Be smart. Be digital.
Page 13 and 14: Utställare Huvudpartner Orion Phar
Page 15 and 16: nyfiken på smofkabiven Läs mer p
Page 17 and 18: ÖVERSIKTSPROGAM SFAI-VECKAN 2012 |
Page 19 and 20: PROGRAM 19
Page 21 and 22: andra länder råder brist på orga
Page 23 and 24: A total of 779 surgical patients fr
Page 25: System av denna typ ger också stor
Page 29 and 30: PEDIATRISK ANESTESI OCH INTENSIVVÅ
Page 31 and 32: KOMMUNIKATION - EDA, BARNMORSKA OCH
Page 33 and 34: BÄSTA AKADEMISKA AVHANDLING INOM A
Page 35 and 36: UT I VÄRLDEN - NÅGOT FÖR DIG Mod
Page 37 and 38: PREHOSPITAL VÅRD SAL 2 9.50-11.20
Page 39 and 40: ABSTRACTS Innehåll: Lista fria fö
Page 41 and 42: Posterpresentationer Postersessione
Page 43 and 44: ytt avdelning/klinik. Riktlinjerna
Page 45 and 46: and newborn mortality is close to 1
Page 47 and 48: tissues in order to achieve satisfa
Page 49 and 50: Methods Fifty-six paediatric cardia
Page 51 and 52: I syfte att öka patientkomforten o
Page 53 and 54: more pronounced under a septic cond
Page 55 and 56: A serum quetiapine level 24 hours a
Page 57 and 58: Comparison of myocardial and plasma
Page 60 and 61: SFAI-VECKAN 2012, 19 - 21 SEPTEMBER
Page 62 and 63: SFAI-VECKAN 2012, 19 - 21 SEPTEMBER
Page 64: HUVUDPARTNER PARTNERS 71mm Print on

Ladda ner den kompletta programboken här! - SFAI-veckan 2013

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?